CLINICAL_TRIALS
trial_result
· 2025-08-13
Clinical Trial Update: Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis [Phase 3]
Summary
Phase 3 long-term extension study of Tapinarof 1% cream for atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2025-08-13